Golestan University of Medical Sciences Repository

A Report from Iranian Primary Immunodeficiency Registry (IPIDR), New Trend in Diagnosis of PID

Fazlollahi, M.R. and Hamidieh, A.A. and Movahedi, M. and Mohammadzadeh, I. and Chavoshzadeh, Z. and Nabavi, M. and Zandieh, F. and Bemanian, M.H. and Mansouri, M. and Atarod, L. and Mahloujirad, M. and Fayezi, A. and Mahdaviani, M. and Kalantari, N. and Bazargan, N. and Behmanesh, F. and Khotaei, G. and Arshi, S. and Pourpak, Z. and Moin, M. (2014) A Report from Iranian Primary Immunodeficiency Registry (IPIDR), New Trend in Diagnosis of PID. JOURNAL OF CLINICAL IMMUNOLOGY, 34 (2). S338.

Full text not available from this repository.

Abstract

Introduction: Primary immunodeficiency disorders (PID) are rare and heterogeneous group of disease. In attempts to ad- dress and to provide an estimate of the precise prevalence of these disorders in Iran, the Iranian Primary Immunodeficiency Registry (IPIDR) was established in 1999. The Registry is currently being expanded and is a part of IAARI (Immunolo- gy, Asthma & Allergy Research Institute). Method: During (2006-2013), 1857 patients who were re- ferred to IAARI with possible diagnosis of PID were enrolled in this study.Primary and advanced screening tests were done and after confirmation of diagnosis all patients registered in IPIDR (Ipidr.tums.ac.ir) Results: fifty hundred and sixty-five patients (354 M/211F) had definite or probable diagnosis of PID; Consanguinity rate and family history of previous child with PID were 58% and 24.6%, respectively. Genetic studies were done in 50.8% of patients and in 37.3% of them specific mutation was found. The most com- mon form of immunodeficiency was congenital defects of phagocyte number, function, or both. (43.5%), mainly chronic granulomatous disease, followed by Well-defined syndromes with immunodeficiency (32.6%), predominantly antibody disor- ders (16%), combined immunodeficiencies (9.7%), Comple- ment deficiencies (8.8%), Diseases of immune dysregulation (7.2%) and defects of innate immunity (2.1%) Conclusion: Recent development in molecular diagnosis can help in early and definite diagnosis of PID. Accurate diagnosis of these conditions are essential for eval uation of PID burden , better decision in prevention and treatment strategies and research studies A Report from Iranian Primary Immunodeficiency Registry (IPIDR), New Trend in Diagnosis of PID (PDF Download Available). Available from: https://www.researchgate.net/publication/268280484_A_Report_from_Iranian_Primary_Immunodeficiency_Registry_IPIDR_New_Trend_in_Diagnosis_of_PID [accessed Jun 20, 2017].

Item Type: Article
Additional Information: 16th Biennial Meeting of the European-Society-for-Immunodeficiencies, Prague, CZECH REPUBLIC, OCT 29-NOV 01, 2014
Subjects: موارد کلی
Divisions: معاونت تحقیقات و فناوری
Depositing User: GOUMS
Date Deposited: 27 Apr 2015 07:29
Last Modified: 20 Jun 2017 04:11
URI: http://eprints.goums.ac.ir/id/eprint/3679

Actions (login required)

View Item View Item